Additionally, increased levels of serotransferrin could also reflect a compensatory mechanism caused by anemia, a condition prevalent among AAA patients, in which the body attempts to increase iron transport in response to decreased levels of hemoglobin [56,57]. This evidence concerns the gene TF and triple-A syndrome.